Ready-to-use 3D human airway organoids that recapitulate mucociliary airway epithelium for respiratory disease modeling, viral infection studies, and pulmonary drug discovery.
- Overview
- Details
- Advantages
- FAQs
Overview
The human airway epithelium serves as the first line of defense against inhaled pathogens, environmental pollutants, and allergens while maintaining critical respiratory functions including mucociliary clearance and epithelial barrier integrity. Conventional 2D airway cell cultures and animal models often fail to fully reproduce the structural complexity, multicellular composition, and physiological responses of the human respiratory tract.
Airway organoids are emerging as advanced in vitro respiratory models for translational pulmonary research. Derived from human induced pluripotent stem cells (hiPSCs) or primary airway epithelial stem cells, airway organoids self-organize into three-dimensional airway-like tissues containing multiple epithelial cell populations and functional lumen structures. These organoids provide a physiologically relevant platform for respiratory disease modeling, viral infection research, and pulmonary drug screening.
What Are Airway Organoids?
Airway organoids are miniature 3D respiratory tissue models generated under defined culture conditions that mimic important structural and functional characteristics of the human airway epithelium.
- Multicellular airway epithelial organization
- Functional ciliated and mucus-producing cells
- Airway barrier and epithelial polarity
- Physiologically relevant host-pathogen interactions
- Cytokine and inflammatory responses
- Long-term culture capability for chronic respiratory studies
Depending on the differentiation strategy and tissue source, airway organoids may contain basal cells, ciliated cells, goblet cells, club cells, and other airway-associated epithelial populations relevant to respiratory biology.
Fig. 1.
Airway organoids are 3D models that are valuable to bridge the knowledge gap between 2D cell line and animal
models (Teo A, Chua C L L, et al., 2022).
Our Ready-to-Use Airway Organoids
Our airway organoids are developed using optimized 3D differentiation and culture technologies to generate highly reproducible human respiratory tissue models suitable for respiratory disease research, infection biology, and pulmonary drug development.
Key Features
- Physiologically relevant airway model. Recapitulates key structural and functional properties of the human airway epithelium.
- Functional mucociliary epithelium. Supports differentiation of ciliated and mucus-producing airway epithelial cells.
- Multicellular complexity. Contains multiple airway-associated epithelial cell populations within a 3D microenvironment.
- Infection-ready platform. Suitable for respiratory virus infection studies including SARS-CoV-2, influenza virus, and RSV.
- Ready-to-use format. Cryopreserved organoids with optimized recovery workflows minimize experimental preparation time.
- Batch-to-batch consistency. Manufactured using standardized protocols and rigorous quality control procedures.
Characterization & Validation
Our airway organoids undergo comprehensive molecular, structural, and functional characterization to ensure biological relevance and reproducibility.
- Airway marker expression: Expression of KRT5, FOXJ1, MUC5AC, TP63, and SCGB1A1 confirmed by immunostaining and qPCR analysis.
- 3D airway morphology: Formation of lumen-containing airway structures with epithelial polarity and organized multicellular architecture.
- Functional validation: Evaluation of ciliary activity, mucus secretion, cytokine responses, and pathogen susceptibility.
- Quality control: High post-thaw viability, mycoplasma-free testing, and batch reproducibility validation.
Applications
Our ready-to-use airway organoids provide a versatile platform for a wide range of respiratory and translational research applications.
- Respiratory Infection Modeling: Study host-pathogen interactions, viral replication, and airway immune responses using physiologically relevant human airway tissue models.
- Respiratory Disease Modeling: Investigate asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), pulmonary fibrosis, and chronic airway inflammation.
- Drug Discovery & Toxicity Screening: Evaluate antiviral compounds, inhaled therapeutics, airway toxicity, and anti-inflammatory drug candidates.
- Personalized Medicine: Combine with patient-derived cells for individualized respiratory disease modeling and therapeutic response assessment.
- Mucosal Immunology Research: Explore epithelial barrier function, cytokine signaling, and airway inflammatory pathways.
- Regenerative Medicine Research: Support airway regeneration and tissue engineering studies.
Why Choose Our Airway Organoids
- Human-relevant airway microenvironment with physiologically relevant epithelial organization
- Functional mucociliary differentiation including ciliated and mucus-producing cells
- More predictive than conventional 2D airway cultures for translational respiratory research
- Infection-compatible platform for respiratory virus and pathogen studies
- Ready-to-use cryopreserved format saves weeks of differentiation and culture optimization
- Reproducible manufacturing with rigorous quality control and batch consistency
- Compatible with multiple downstream assays including imaging, molecular analysis, and infection studies
FAQs
Q: How are airway organoids shipped?
Airway organoids are shipped in cryopreserved vials on dry ice or in liquid nitrogen vapor shippers to maintain optimal viability and structural integrity during transportation.
Q: What airway cell types are present in the organoids?
Depending on the differentiation conditions, airway organoids may contain basal cells, ciliated cells, goblet cells, club cells, and other airway-associated epithelial populations.
Q: Are airway organoids suitable for respiratory virus research?
Yes. Airway organoids provide a physiologically relevant platform for studying respiratory virus infection, viral replication, epithelial injury, and antiviral drug responses.
Q: Can airway organoids be cultured long-term?
Under optimized culture conditions, airway organoids can be maintained for extended periods to support chronic respiratory disease modeling and long-term treatment studies.
Accelerate your respiratory research with physiologically relevant, ready-to-use human airway organoids.
Contact us today to request detailed datasheets, pricing information, or customized airway organoid solutions tailored to your respiratory research needs.
Online Inquiry